Rhenman & Partners Asset Management Ab Position In Edwards Lifesciences (EW) Was Increased; As Quanta Services (PWR) Stock Value Declined, Argent Capital Management Has Cut Holding by $735,075

Edwards Lifesciences Corporation (NYSE:EW) Logo

Argent Capital Management Llc decreased its stake in Quanta Services Inc. (PWR) by 18.33% based on its latest 2018Q3 regulatory filing with the SEC. Argent Capital Management Llc sold 22,275 shares as the company’s stock declined 10.73% with the market. The institutional investor held 99,225 shares of the capital goods company at the end of 2018Q3, valued at $3.31 million, down from 121,500 at the end of the previous reported quarter. Argent Capital Management Llc who had been investing in Quanta Services Inc. for a number of months, seems to be less bullish one the $4.73 billion market cap company. The stock decreased 0.14% or $0.04 during the last trading session, reaching $32.26. About 882,313 shares traded. Quanta Services, Inc. (NYSE:PWR) has declined 20.13% since January 14, 2018 and is downtrending. It has underperformed by 20.13% the S&P500. Some Historical PWR News: 03/05/2018 – Quanta Services 1Q EPS 24c; 18/04/2018 – Quanta Services Closes Below 50-Day Moving Average: Technicals; 22/05/2018 – Quanta Services Presenting at Conference May 30; 25/04/2018 – ASETEK RECEIVES CONFIRMATION OF HPC AWARD FROM QUANTA COMPUTER; 03/05/2018 – Quanta Services Sees 2018 EPS $2.07-EPS $2.47; 09/03/2018 QUANTA COMPUTER 2382.TW SAYS FEB SALES DOWN 13.3 PCT Y/Y; 16/05/2018 – Quanta Services Rises for 10 Days; Tied for Longest Rally; 03/05/2018 – QUANTA SERVICES INC – INCREASES 2018 REVENUE AND EARNINGS PER SHARE EXPECTATIONS; 10/04/2018 – TAIWAN’S QUANTA COMPUTER 2382.TW SAYS MARCH SALES DOWN 2.65 PCT Y/Y; 03/05/2018 – QUANTA SERVICES INC PWR.N SEES FY 2018 SHR $2.07 TO $2.47

Rhenman & Partners Asset Management Ab increased its stake in Edwards Lifesciences Corp (EW) by 41.28% based on its latest 2018Q3 regulatory filing with the SEC. Rhenman & Partners Asset Management Ab bought 28,221 shares as the company’s stock rose 13.75% while stock markets declined. The institutional investor held 96,585 shares of the industrial specialties company at the end of 2018Q3, valued at $16.82M, up from 68,364 at the end of the previous reported quarter. Rhenman & Partners Asset Management Ab who had been investing in Edwards Lifesciences Corp for a number of months, seems to be bullish on the $31.45 billion market cap company. The stock decreased 1.54% or $2.35 during the last trading session, reaching $150.45. About 578,948 shares traded. Edwards Lifesciences Corporation (NYSE:EW) has risen 37.86% since January 14, 2018 and is uptrending. It has outperformed by 37.86% the S&P500. Some Historical EW News: 24/04/2018 – EDWARDS LIFESCIENCES – CONTINUES TO EXPECT THVT FY UNDERLYING SALES GROWTH RATE TO BE AT HIGHER END OF 11 PCT TO 15 PCT; 24/04/2018 – Edwards Lifesciences 1Q Net $206.6M; 22/05/2018 – Real-World Evidence Confirms Clinical Trial Outcomes For Patients Treated With Edwards SAPIEN 3 Valve; 28/03/2018 – BOSTON SCIENTIFIC PREVAILS IN U.K. EDWARDS LIFESCIENCES LITIGAT; 25/04/2018 – EDWARDS LIFESCIENCES CORP EW.N : NORTHLAND CAPITAL CUTS TO MARKET PERFORM RATING; 24/04/2018 – EDWARDS LIFESCIENCES CORP FY2018 SHR VIEW $4.53, REV VIEW $3.85 BLN — THOMSON REUTERS l/B/E/S; 24/04/2018 – Edwards Lifesciences Raises 2018 View To Adj EPS $4.50-Adj EPS $4.70; 21/03/2018 – Edwards Completes Enrollment In PARTNER 3 Low-Risk CT Sub-Study, Updates Timeline For SAPIEN 3 Ultra System Launch In Europe; 24/04/2018 – EDWARDS LIFESCIENCES – REMAINS CONFIDENT IN ACHIEVING HIGHER END OF 2018 SALES OUTLOOK RANGE OF $3.5 BLN TO $3.9 BLN; 24/04/2018 – After-hours buzz: TXN, WYNN, EW & more

More recent Edwards Lifesciences Corporation (NYSE:EW) news were published by: Seekingalpha.com which released: “Centene finishes first, Coty last on S&P 500 for 2018 – Seeking Alpha” on December 31, 2018. Also Seekingalpha.com published the news titled: “Credit Suisse sees 18% upside in Abbott in premarket analyst action – Seeking Alpha” on December 18, 2018. Benzinga.com‘s news article titled: “Benzinga’s Top Upgrades, Downgrades For January 3, 2019 – Benzinga” with publication date: January 03, 2019 was also an interesting one.

Among 30 analysts covering Edwards Lifesciences Corp (NYSE:EW), 19 have Buy rating, 2 Sell and 9 Hold. Therefore 63% are positive. Edwards Lifesciences Corp had 128 analyst reports since July 30, 2015 according to SRatingsIntel. BMO Capital Markets maintained Edwards Lifesciences Corporation (NYSE:EW) on Monday, April 4 with “Outperform” rating. The rating was initiated by Suntrust Robinson on Friday, January 8 with “Neutral”. The company was maintained on Tuesday, September 5 by Jefferies. The rating was maintained by JP Morgan with “Neutral” on Friday, July 27. The company was maintained on Friday, February 2 by JMP Securities. The rating was maintained by Morgan Stanley on Thursday, October 11 with “Overweight”. On Thursday, January 21 the stock rating was upgraded by Suntrust Robinson to “Buy”. As per Friday, September 1, the company rating was maintained by RBC Capital Markets. The stock of Edwards Lifesciences Corporation (NYSE:EW) has “Buy” rating given on Tuesday, October 10 by Jefferies. Jefferies maintained Edwards Lifesciences Corporation (NYSE:EW) on Monday, April 4 with “Buy” rating.

Rhenman & Partners Asset Management Ab, which manages about $997.99 million US Long portfolio, decreased its stake in Eli Lilly & Co (NYSE:LLY) by 30,000 shares to 170,000 shares, valued at $18.24 million in 2018Q3, according to the filing. It also reduced its holding in Anthem Inc (NYSE:ANTM) by 6,000 shares in the quarter, leaving it with 70,000 shares, and cut its stake in Aetna Inc (NYSE:AET).

Argent Capital Management Llc, which manages about $2.51 billion and $2.92B US Long portfolio, upped its stake in Red Hat Inc. (NYSE:RHT) by 9,222 shares to 422,490 shares, valued at $57.58M in 2018Q3, according to the filing. It also increased its holding in Ii Vi Incorporated (NASDAQ:IIVI) by 17,875 shares in the quarter, for a total of 101,390 shares, and has risen its stake in Flir Systems Inc. (NASDAQ:FLIR).

Among 15 analysts covering Quanta Services Inc. (NYSE:PWR), 12 have Buy rating, 0 Sell and 3 Hold. Therefore 80% are positive. Quanta Services Inc. had 54 analyst reports since August 6, 2015 according to SRatingsIntel. Robert W. Baird downgraded the shares of PWR in report on Wednesday, July 26 to “Hold” rating. FBR Capital maintained Quanta Services, Inc. (NYSE:PWR) on Monday, February 26 with “Buy” rating. Stifel Nicolaus maintained Quanta Services, Inc. (NYSE:PWR) rating on Friday, September 23. Stifel Nicolaus has “Buy” rating and $32.50 target. The stock of Quanta Services, Inc. (NYSE:PWR) earned “Buy” rating by Citigroup on Friday, November 2. As per Thursday, November 12, the company rating was downgraded by Robert W. Baird. The company was maintained on Monday, November 9 by FBR Capital. The stock of Quanta Services, Inc. (NYSE:PWR) earned “Buy” rating by Stifel Nicolaus on Friday, January 26. FBR Capital maintained it with “Outperform” rating and $29 target in Monday, August 10 report. The firm has “Outperform” rating by Robert W. Baird given on Tuesday, November 15. As per Tuesday, September 5, the company rating was maintained by Robert W. Baird.

Analysts await Quanta Services, Inc. (NYSE:PWR) to report earnings on February, 28. They expect $0.85 earnings per share, up 112.50% or $0.45 from last year’s $0.4 per share. PWR’s profit will be $124.52M for 9.49 P/E if the $0.85 EPS becomes a reality. After $0.82 actual earnings per share reported by Quanta Services, Inc. for the previous quarter, Wall Street now forecasts 3.66% EPS growth.

Quanta Services, Inc. (NYSE:PWR) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.